26616 Federal Register / Vol. 65, No. 89 / Monday, May 8, 2000 / Notices

full text of the consent agreement

package can be obtained from the FTC

Home Page (for May 1, 2000), on the

World Wide Web, at ‘‘http://

www.ftc.gov/ftc/formal.htm.’’ A paper

copy can be obtained from the FTC

Public Reference Room, Room H–130,

600 Pennsylvania Avenue, NW,

Washington, D.C. 20580, either in

person or by calling (202) 326–3627.

Public comment is invited. Comments

should be directed to: FTC/Office of the

Secretary, Room 159, 600 Pennsylvania

Ave., NW, Washington, D.C. 20580. Two

paper copies of each comment should

be filed, and should be accompanied, if

possible, by a 31⁄2 inch diskette

containing an electronic copy of the

comment. Such comments or views will

be considered by the Commission and

will be available for inspection and

copying at its principal office in

accordance with § 4.9(b)(6)(ii) of the

Commission’s Rules of Practice (16 CFR

4.9(b)(6)(ii)).

Analysis of Proposed Consent Order To

Aid Public Comment

The Federal Trade Commission has

accepted, subject to final approval, an

agreement containing a consent order

from CompuTrade LLC, a corporation,

and Bernard Lewis, individually and as

an officer of the corporation (together,

‘‘respondents’’).

The proposed consent order has been

placed on the public record for thirty

(30) days for receipt of comments by

interested persons. Comments received

during this period will become part of

the public record. After thirty (30) days,

the Commission will again review the

agreement and the comments received,

and will decide whether it should

withdraw from the agreement or make

final the agreement’s proposed order.

Respondents sell and distribute

computer software and training for

buying and selling foreign currencies on

a daily basis. They advertise on their

Internet Web sites,

www.computrades.com and

www.computrader.net. This matter

concerns allegedly deceptive

representations of the earnings and

profit potential, as well as the extent of

risk involved in using respondent’s

trading methods.

The Commission’s proposed

complaint alleges that respondents

made unsubstantiated claims that users

of respondents’ currency trading

program could reasonably expect to earn

large profits of $500 to $750 or more per

day, and as much as six or seven figures

annually (i.e., more than $1,000,000);

that users could reasonably expect to

earn huge profits even if they had no

previous experience in currency trading;

and that testimonials appearing in the

advertisements for respondents’

currency trading program reflected the

typical or ordinary experience of

members of the public who use the

program. In addition, the complaint

alleges that respondents misrepresented

that users of their currency trading

program could reasonably expect to

trade with little financial risk.

The proposed consent order contains

provisions designed to prevent

respondents from engaging in similar

acts and practices in the future.

Part I of the proposed order requires

respondents to have a reasonable basis

substantiating any representation that

users of respondents’ currency trading

program can reasonably expect to earn

large profits: (1) of $500 to $750 or more

per day; (2) of as much as six or even

seven figures annually (i.e., more than

$1,000,000); or (3) even if they have no

previous experience in currency trading.

Part I also requires respondents to

possess a reasonable basis substantiating

claims about the amount of earnings,

income, or profit that a prospective user

of any trading program could reasonably

expect to attain, or about any financial

benefit or other benefit from any trading

program offered by respondents.

Part II of the proposed order prohibits

respondents from misrepresenting that

users of any trading program can

reasonably expect to trade with little or

no financial risk and from

misrepresenting the extent of risk to

which users of any such program are

exposed.

Part III of the proposed order requires

respondents to disclose, clearly and

conspicuously, ‘‘CURRENCY [or

STOCK, COMMODITY FUTURES,

OPTIONS, ETC., as applicable]

TRADING involves high risks and YOU

can LOSE a lot of money,’’ in close

proximity to any representation they

make about the financial benefits of any

trading program. This disclosure is in

addition to, and not instead of, any

other disclosure that respondents may

be required to make.

Part IV of the proposed order

prohibits respondents from representing

without a reasonable basis that the

experience represented by any user,

testimonial or endorsement of any

trading program represents the typical

or ordinary experience of members of

the public who use the program; or

respondents must disclose either what

the generally expected results would be

for users of the trading program, or the

limited applicability of the endorser’s

experience to what users may generally

expect to achieve, that is, that users

should not expect to experience similar

results.

Parts V and VI of the proposed order

require respondents to keep copies of

relevant advertisements and materials

substantiating claims made in the

advertisements and to provide copies of

the order to certain personnel. Part VII

requires CompuTrade to notify the

Commission of any changes in the

corporate structure that might affect

compliance with the order. Part VIII

requires that the individual respondent

notify the Commission of changes in his

employment status for a period of ten

years. Part IX requires CompuTrade to

file compliance reports with the

Commission. Part X provides that the

order will terminate after twenty (20)

years under certain circumstances.

The purpose of this analysis is to

facilitate public comment on the

proposed order. It is not intended to

constitute an official interpretation of

the agreement and proposed order or to

modify in any way their terms.

By direction of the Commission.

Donald S. Clark,

Secretary.

[FR Doc. 00–11456 Filed 5–5–00; 8:45 am]

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Council for the Elimination of

Tuberculosis: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following council

meeting.

Name: Advisory Council for the

Elimination of Tuberculosis (ACET).

Times and Dates: 8:30 a.m.–5 p.m.,

June 7, 2000 and 8:30 a.m.–12 p.m.,

June 8, 2000.

Place: Marriott Atlanta Century

Center, 2000 Century Boulevard NE,

Atlanta, Georgia 30345.

Status: Open to the public, limited

only by the space available. The meeting

room accommodates approximately 100

people.

Purpose: This council advises and

makes recommendations to the

Secretary of Health and Human

Services, the Assistant Secretary for

Health, and the Director, CDC, regarding

the elimination of tuberculosis.

Specifically, the Council makes

recommendations regarding policies,

strategies, objectives, and priorities;

addresses the development and

application of new technologies; and

Federal Register / Vol. 65, No. 89 / Monday, May 8, 2000 / Notices 26617

reviews the extent to which progress has

been made toward eliminating

tuberculosis.

Matters To Be Discussed: Agenda

items include issues pertaining to the

epidemiology and control of

Tuberculosis in low incidences counties

and TB research priorities.

CONTACT PERSON FOR MORE INFORMATION:

Paulette Ford, National Center for HIV,

STD, and TB Prevention, 1600 Clifton

Road, NE, M/S E–07, Atlanta, Georgia

30333, telephone 404/639–8008.

The Director, Management Analysis

and Services Office, has been delegated

the authority to sign Federal Register

Notices pertaining to announcements of

meetings and other committee

management activities, for both the

Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: May 1, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–11383 Filed 5–5–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

National Vaccine Advisory Committee,

Subcommittee on Future Vaccines,

Subcommittee on Immunization

Coverage, and Subcommittee on

Vaccine Safety and Communication

Meetings

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following Federal

advisory committee meetings.

Name: National Vaccine Advisory

Committee (NVAC).

Times and Dates: 9 a.m.–2:15 p.m., May

22, 2000; 8:30 a.m.–12:45 p.m., May 23, 2000.

Place: Hubert H. Humphrey Building,

Room 505A, 200 Independence Avenue, SW,

Washington, DC 20201.

Status: Open to the public, limited only by

the space available.

Notice: In the interest of security, the

Department has instituted stringent

procedures for entrance to the Hubert H.

Humphrey Building by non-government

employees. Thus, persons without a

government identification card should plan

to arrive at the building each day either

between 8:00 a.m. and 8:30 a.m. or 12:30

p.m. and 1:00 p.m. Entrance to the meeting

at other times during the day cannot be

assured.

Purpose: This committee advises and

makes recommendations to the Director of

the National Vaccine Program on matters

related to the Program responsibilities.

Matters to be Discussed: Agenda items will

include: an update on the National Vaccine

Program Office (NVPO) activities; an update

on Unmet Needs Funding; Influenza

Vaccine—New Technologies; Pandemic

Planning and Adult Immunization;

Bioterrorism—Advisory Committee on

Immunization Practices (ACIP)/NVAC

Activities; Large Population Immunization;

Immunization Registries Funding Issues;

Vaccine Safety and Communication

Subcommittee Report; update from the Office

of the Assistant Secretary for Health and

Surgeon General; Immunization Coverage

Subcommittee Report; Future Vaccines

Subcommittee Report; ACIP Annual Report;

a report on NVAC Poliovirus Containment

Workgroup; Together for Tots/Preventive

Services Collaborative.

Name: Subcommittee on Future Vaccines.

Time and Date: 2:15 p.m.–5 p.m., May 22,

2000.

Place: Hubert H. Humphrey Building,

Room 305A, 200 Independence Avenue, SW,

Washington, DC 20201.

Status: Open to the public, limited only by

the space available.

Purpose: This subcommittee develops

policy options and guides national activities

that lead to accelerated development,

licensure, and the best use of new vaccines

in the simplest possible immunization

schedules.

Matters to be Discussed: Agenda items will

include discussions on the Institute of

Medicine Report ‘‘Vaccines for the 21st

Century’’ Cytomegalovirus (CMV) Workshop

planned meeting; Vaccines for Chronic

diseases meeting.

Name: Subcommittee on Immunization

Coverage.

Time and Date: 2:15 p.m.–5 p.m., May 22,

2000.

Place: Hubert H. Humphrey Building,

Room 505A, 200 Independence Avenue, SW,

Washington, DC 20201.

Status: Open to the public, limited only by

the space available.

Purpose: This subcommittee will identify

and propose solutions that provide a

multifaceted and holistic approach to

reducing barriers that result in low

immunization coverage for children.

Matters to be Discussed: Agenda items will

include adolescent immunization coverage

rates; review of the Adult Immunization

Standards’ document; immunization

requirements for school entry and

philosophical exemptions; update on unmet

needs; the roll-out process for the ‘‘Strategies

to Sustain Success’’ and the Adult

Immunization Action Plan.

Name: Subcommittee on Vaccine Safety

and Communication.

Time and Date: 2:15 p.m.–5 p.m., May 22,

2000.

Place: Hubert H. Humphrey Building,

Room 325A, 200 Independence Avenue, SW,

Washington, DC 20201.

Status: Open to the public, limited only by

the space available.

Purpose: This subcommittee reviews issues

relevant to vaccine safety and adverse

reactions to vaccines.

Matters to be Discussed: Communication

Workshop; Vaccine Safety Surveillance; and

Standards for Pediatric Immunization

Practices.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Gloria Sagar, Committee Management

Specialist, NVPO, CDC, 1600 Clifton Road,

NE, M/S D–66, Atlanta, Georgia 30333,

telephone 404/687–6672.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register Notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: May 3, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 00–11516 Filed 5–5–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

President’s Committee on Mental

Retardation; Notice of Meeting

AGENCY: President’s Committee on

Mental Retardation, HHS.

ACTION: Notice of meeting.

DATES: Friday, June 2, 2000 from 9 to 1.

Place: Hotel Washington, 515 15th

Street, NW, Washington, DC. 20004–

1099.

Full Committee Meetings are open to

the public. An interpreter for the deaf

will be available upon advance request.

All meeting sites are barrier free.

Agenda: The Committee plans to

discuss critical issues concerning

Federal Policy, Federal Research and

Demonstration, State Policy

Collaboration, Minority and Cultural

Diversity and Mission and Public

Awareness, relating to individuals with

mental retardation.

SUPPLEMENTARY INFORMATION: The PCMR

acts in an advisory capacity to the

President and the Secretary of the U.S.

Department of Health and Human

Services on a broad range of topics

related to programs, services, and

supports for persons with mental

retardation. The Committee, by

Executive Order, is responsible for

evaluating the adequacy of current

practices in programs and supports for